narciclasine has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badhe, BA; Bhat, BV; Dhas, BB; Kingsley, MK; Parija, SC | 1 |
| Chen, J; Duan, Q; Hu, H; Jia, Y; Jin, Y; Qin, Y | 1 |
2 other study(ies) available for narciclasine and Lung Injury, Acute
| Article | Year |
|---|---|
Narciclasine improves outcome in sepsis among neonatal rats via inhibition of calprotectin and alleviating inflammatory responses.
Topics: Acute Lung Injury; Amaryllidaceae Alkaloids; Anemia; Animals; Animals, Newborn; Bacterial Load; Inflammation; Inflammation Mediators; Interleukin-6; Leukocyte L1 Antigen Complex; Liver; Phenanthridines; Phosphorylation; Rats; S100 Proteins; Sepsis; Signal Transduction; Survival Analysis; Toll-Like Receptor 4; Transcription Factor RelA; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Narciclasine attenuates LPS-induced acute lung injury in neonatal rats through suppressing inflammation and oxidative stress.
Topics: Acute Lung Injury; Amaryllidaceae Alkaloids; Animals; Animals, Newborn; In Situ Nick-End Labeling; Inflammation; Lipopolysaccharides; Lung Injury; Male; Oxidative Stress; Phenanthridines; Rats; Reactive Oxygen Species; Signal Transduction | 2020 |